HIV Prevention Trials Network

Studies

HPTN 039

A Phase III, randomized, double-blind, placebo-controlled trial of acyclovir for the reduction of HIV acquisition among high risk HSV-2 seropositive, HIV-seronegative individuals

 

Meetings and Presentations

HPTN 039 WSM Retreat (May 18-19, 2007)
Download Retreat notebook documents (zip file)

HPTN Annual Meeting 039 Session, February 22, 2006

Africa Team: Zimbabwe-Zambia-South Africa Training & Implementation Summit #2, January 20-22, 2006

Individual Report Sections

Site Map | HPTN Disclaimer | Webmaster | ©2008 Family Health International